CS logo
small CS logo
MVZ Onkologische Kooperation Harz

Goslar, Germany
Oncologist in Goslar, Lower Saxony
Kösliner Str. 14, 38642 Goslar

About MVZ Onkologische Kooperation Harz


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at MVZ Onkologische Kooperation Harz


During the past decade, MVZ Onkologische Kooperation Harz conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast Cancer
1996-05-01
Completed
342
Exenatide Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and Metformin
2003-11-01
2008-07-01
Completed
505
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
2005-09-01
2008-12-01
Terminated
277
A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study)
2003-07-01
Completed
860
Efficacy and Safety of Tiotropium Inhalation Capsules and Atrovent MDI in Patients With Chronic Obstructive Pulmonary Disease (COPD)
2002-09-01
2003-10-01
Completed
132
A Study of ADH300004 and 5-Fluorouracil in Locally Advanced, Recurrent, or Metastatic Hepatocellular Carcinoma
Terminated
Randomized Phase I/II of RAD001 in Advanced Hepatocellular Carcinoma (HCC)
2006-10-01
2011-06-01
Unknown status
134
Safety Study of Anti-Asthma Agent BMEC-1217B
2008-07-01
Unknown status
32

Rows per page:

1–100 of 228

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "MVZ Onkologische Kooperation Harz" #1 sponsor was "AIO-Studien-gGmbH" with 2 trials, followed by "German CLL Study Group" with 2 trials sponsored, "Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest" with 2 trials sponsored, "iOMEDICO AG" with 2 trials sponsored and "AGO Research GmbH" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "MVZ Onkologische Kooperation Harz" #1 collaborator was "German Breast Group" with 2 trials as a collaborator, "Roche Pharma AG" with 2 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 25 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at MVZ Onkologische Kooperation Harz


According to Clinical.Site data, the most researched conditions in "MVZ Onkologische Kooperation Harz" are "Breast Cancer" (2 trials), "Cholangiocarcinoma" (2 trials), "Chronic Lymphoid Leukemia" (2 trials), "Gallbladder Cancer" (2 trials) and "Hepatocellular Cancer" (2 trials). Many other conditions were trialed in "MVZ Onkologische Kooperation Harz" in a lesser frequency.

Clinical Trials Intervention Types at MVZ Onkologische Kooperation Harz


Most popular intervention types in "MVZ Onkologische Kooperation Harz" are "Drug" (7 trials), "Biological" (3 trials), "Behavioral" (1 trials), "Combination Product" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.
The name of intervention was led by "Acalabrutinib" (1 trials), "Bevacizumab" (1 trials), "Capecitabine + bevacizumab OR Paclitaxel +/- bevacizumab" (1 trials), "Carboplatin" (1 trials) and "Concomitant coaching" (1 trials). Other intervention names were less common.

Clinical Trials Genders at MVZ Onkologische Kooperation Harz


The vast majority of trials in "MVZ Onkologische Kooperation Harz" are 12 trials for "All" genders and 3 trials for "Female" genders.

Clinical Trials Status at MVZ Onkologische Kooperation Harz


Currently, there are NaN active trials in "MVZ Onkologische Kooperation Harz". undefined are not yet recruiting, 6 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in MVZ Onkologische Kooperation Harz, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in MVZ Onkologische Kooperation Harz, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status